AHL Partners
ISEE

AHL Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

AHL Partners’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6,482
Closed -$299K – 1217
2016
Q3 		$299K Buy
+6,482
New +$366K 0.01% 981
2015
Q3 		– Sell
-101,406
Closed -$5.28M – 838
2015
Q2 		$5.28M Sell
101,406
-11,582
-10% -$576K 0.21% 152
2015
Q1 		$5.26M Buy
+112,988
New +$5.87M 0.21% 158

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stonepine Capital Management
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Tourbillon Capital Partners
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Bogle Investment Management
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AHL Partners's ISEE Position: Q4 2016 in Review

AHL Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 6,482 shares — an estimated $299K sold.

AHL Partners first reported a position in ISEE in Q1 2015 and held it in 3 quarters. The position peaked at $5.28M in Q2 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • AHL Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • AHL Partners sold 6,482 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $299K.
  • AHL Partners first reported a position in IVERIC bio, Inc. Common Stock in Q1 2015 and held it in 3 quarters.
  • AHL Partners's IVERIC bio, Inc. Common Stock position peaked at $5.28M in Q2 2015.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on AHL Partners's 13F filing for Q4 2016, filed 14 Feb 2017.